Literature DB >> 3917713

Why do patients with lupus nephritis die?

P Correia, J S Cameron, J D Lian, J Hicks, C S Ogg, D G Williams, C Chantler, D G Haycock.   

Abstract

Over 20 years 42 of 138 patients with systemic lupus erythematosus "died"--that is, suffered actual death or went into terminal renal failure, or both; data from 41 were available for analysis. In most patients the causes of death were multiple. Twenty seven patients went into terminal renal failure, of whom 25 were offered dialysis treatment. Three regained renal function later, 12 survived on dialysis or with functioning kidney allografts--almost all with inactive lupus--but 13 died after starting dialysis, most within a few weeks or months. The principal causes were active lupus or infection. In those patients with renal failure after rapid deterioration in renal function (n = 14) there were nine deaths, while of 10 patients with a slow evolution into renal failure, only four died. Four patients with impaired and 10 with normal renal function died, again most often from complications of lupus or from infection. Vascular disease was a major cause of death in seven patients, all but two of whom were young; of 15 postmortem examinations, eight showed severe coronary artery atheroma, and three surviving patients required coronary bypass operations. Analysis of the timing of death or entry into renal failure showed that in 12 out of 13 patients who died within two years of onset the lupus was judged to be active, while this was true in only eight out of 19 patients who died later. Six of the seven vascular deaths occurred later than two years from onset, while only nine of 26 renal "deaths" occurred before two years; deaths from infections (n = 13) were distributed equally. Despite this and aggressive treatment of active disease, the principal cause of actual death was uncontrolled lupus.

Entities:  

Mesh:

Year:  1985        PMID: 3917713      PMCID: PMC1415465          DOI: 10.1136/bmj.290.6462.126

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  37 in total

1.  THE NATURAL HISTORY OF THE RENAL MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS.

Authors:  V E POLLAK; C L PIRANI; F D SCHWARTZ
Journal:  J Lab Clin Med       Date:  1964-04

2.  Hemodialysis on end-stage lupus nephritis.

Authors:  N Coplon; R Siegel; J Fries
Journal:  Trans Am Soc Artif Intern Organs       Date:  1973

3.  Duration and death in systemic lupus erythematosus. An analysis of 249 cases.

Authors:  E L Dubois; M Wierzchowiecki; M B Cox; J M Weiner
Journal:  JAMA       Date:  1974-03-25       Impact factor: 56.272

4.  Acute renal failure in systemic lupus erythematosus.

Authors:  C Ponticelli; E Imbasciati; D Brancaccio; A Tarantino; E Rivolta
Journal:  Br Med J       Date:  1974-09-21

Review 5.  The natural history of systemic lupus erythematosus by prospective analysis.

Authors:  D Estes; C L Christian
Journal:  Medicine (Baltimore)       Date:  1971-03       Impact factor: 1.889

6.  Mortality in systemic lupus erythematosus: a 10-year review.

Authors:  P H Feng; P S Cheah; Y K Lee
Journal:  Br Med J       Date:  1973-12-29

7.  Coronary arteritis, occlusion, and myocardial infarction due to lupus erythematosus.

Authors:  T A Bonfiglio; R E Botti; J W Hagstrom
Journal:  Am Heart J       Date:  1972-02       Impact factor: 4.749

8.  Myocardial infarction due to coronary atherosclerosis in three young adults with systemic lupus erythematosus.

Authors:  J Meller; C A Conde; L M Deppisch; E Donoso; S Dack
Journal:  Am J Cardiol       Date:  1975-02       Impact factor: 2.778

9.  The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients.

Authors:  B H Bulkley; W C Roberts
Journal:  Am J Med       Date:  1975-02       Impact factor: 4.965

10.  Experimental induction of athero-arteriosclerosis by the synergy of allergic injury to arteries and lipid-rich diet. I. Effect of repeated injections of horse serum in rabbits fed a dietary cholesterol supplement.

Authors:  C R Minick; G E Murphy; W G Campbell
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

View more
  8 in total

1.  Lupus nephritis. Middlesex, October 20, 1988. Abstracts.

Authors: 
Journal:  Postgrad Med J       Date:  1989-05       Impact factor: 2.401

2.  Fatal cardiac failure due to myocardial microthrombi in systemic lupus erythematosus.

Authors:  J H Brown; C C Doherty; D C Allen; P Morton
Journal:  Br Med J (Clin Res Ed)       Date:  1988-05-28

3.  Deterioration of renal function in a patient with lupus.

Authors:  E C Rankin; G H Nield; D A Isenberg
Journal:  Ann Rheum Dis       Date:  1994-01       Impact factor: 19.103

Review 4.  Current treatment recommendations for lupus nephritis.

Authors:  C Ponticelli
Journal:  Drugs       Date:  1990-07       Impact factor: 9.546

Review 5.  The treatment of lupus nephritis.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

Review 6.  Lupus nephritis in childhood and adolescence.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1994-04       Impact factor: 3.714

7.  The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL/MP-lpr/lpr mice.

Authors:  F P Huang; G J Feng; G Lindop; D I Stott; F Y Liew
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

8.  Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis.

Authors:  George K Bertsias; Maria Tektonidou; Zahir Amoura; Martin Aringer; Ingeborg Bajema; Jo H M Berden; John Boletis; Ricard Cervera; Thomas Dörner; Andrea Doria; Franco Ferrario; Jürgen Floege; Frederic A Houssiau; John P A Ioannidis; David A Isenberg; Cees G M Kallenberg; Liz Lightstone; Stephen D Marks; Alberto Martini; Gabriela Moroni; Irmgard Neumann; Manuel Praga; Matthias Schneider; Argyre Starra; Vladimir Tesar; Carlos Vasconcelos; Ronald F van Vollenhoven; Helena Zakharova; Marion Haubitz; Caroline Gordon; David Jayne; Dimitrios T Boumpas
Journal:  Ann Rheum Dis       Date:  2012-07-31       Impact factor: 19.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.